Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
After a single intravenous (IV) administration, single intramuscular (IM) administrations at three doses in successive increments along with repeated IM administrations, the elimination half-life (t 1/2 ) of prototype BPC157 was less than 30 min, and BPC157 showed linear pharmacokinetic characteristics in rats and beagle dogs at all doses
TB-500 has been well-tolerated in various research applications, with its endogenous nature (as Thymosin Beta-4) suggesting compatibility with normal physiology
In hindlimb ischemia models, the peptide accelerates blood flow recovery as measured by laser Doppler scanning, with histological analysis confirming increased vessel numbers and enhanced vascular expression of VEGFR2
7,8-benzoflavone)
TB-500 Side Effects Researchers are still in the process of determining what, if any, side effects may result from TB-500 administration
